Uncoupling p70s6 kinase activation and proliferation: Rapamycin-resistant proliferation of human CD8+ T lymphocytes1

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3201-3209

  Slavik, J M ^a   Lim, D G ^a   Burakoff, S J ^a   Hafler, D A ^a  

^a Center for Neurologic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE ANTIBODY; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; MACROLIDE; RAPAMYCIN; S6 KINASE;

ARTICLE; CLONE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME INHIBITION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0035284805     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3201     Document Type: Article

References (42)

1. Inhibition of the immune response by rapamycin, a new fungal antibiotic
2. Identification of a new pharmacologic action for an old compound
3. Mechanism of action of the immunosuppressant rapamycin
4. Immunopharmacology of rapamycin
5. Rapamycin inhibits the generation of graft-versus-host disease and graft-versus-leukemia causing T cells by interfering with the production of Th1 or Th2 cytotoxic cytokines
6. Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens
7. Progress with cyclosporine-sparing regimens
8. Rapamycin on trial
9. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
10. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A
11. Mechanisms of action of the immunosuppressants: Cyclosporin A, FK506 and rapamycin
12. Calcineurin: Structure, function and inhibition
13. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between immunophilin and either FK506 or rapamycin
14. The chemistry of signal transduction
15. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells
16. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
17. 1-arresting rapamycin-receptor complex
18. RAPT1, a mammalian homolog of yeast TOR, interacts with the FKBP12/rapamycin complex
19. Target of rapamycin (TOR): Balancing the opposing forces of protein synthesis and degradation
20. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BPI
21. Rapamycin-induced inhibition of the 70-kilodalton S6 kinase
22. Interleukin-2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin
23. Gene targeting: Applications in transplantation research
24. Three-dimensional segregation of supramolecular activation clusters in T cells
25. The immunological synapse: A molecular machine controlling T cell activation
26. Significance of T-cell stimulation by altered peptide ligands in T cell biology
27. The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation
28. + T cells specific to a single viral epitope
29. + T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions
30. + T cells via signal 1 alone
31. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28
32. CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: Analysis of early and late activation events
33. Ribosomal S6 kinase signaling and the control of translation
34. S6K; a role in regulating cell motility
35. Distribution of IL-15 receptor α-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression
36. Effect of rapamycin on the expression of the IL-2 receptor (CD25)
37. Evidence that rapamycin has differential effects of IL-4 function: Multiple signaling pathways and implications for in vivo use
38. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: Evidence for TRAIL induction via the T cell receptor signaling pathway
39. Activation of 70 kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation
40. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase
41. Studies on the mechanism of resistance to rapamycin in human cancer cells
42. Newer immunosuppressive drugs: A review